Serum potassium concentrations were measured after administration of suxamethonium (1 mg/kg body wt.) in 101 patients in whom anaesthesia was induced by one of five different techniques. There was a maYimnm increase in serum potassium of 21.4% following induction with trichloroethylene compared with 4.4% with nitrous oxide/ oxygen. There were only small increases in serum potassium with halothane and chloroform. In an additional 10 patients who received tubocurarine (3 mg) before induction of anaesthesia with thiopentone, the maximum increase in serum potassium was 10.6% following suxamethonium. It is concluded that the increase in serum potassium following induction of anaesthesia is the result of a combined effect of the anaesthetic agent and suxamethonium.
Serum potassium concentrations were measured after administration of suxamethonium (1 mg/kg body wt.) in 101 patients in whom anaesthesia was induced by one of five different techniques. There was a maYimnm increase in serum potassium of 21.4% following induction with trichloroethylene compared with 4.4% with nitrous oxide/ oxygen. There were only small increases in serum potassium with halothane and chloroform. In an additional 10 patients who received tubocurarine (3 mg) before induction of anaesthesia with thiopentone, the maximum increase in serum potassium was 10.6% following suxamethonium. It is concluded that the increase in serum potassium following induction of anaesthesia is the result of a combined effect of the anaesthetic agent and suxamethonium.
It is well established that, in patients, there is a transient hyperkalaemia following the administration of suxamethonium (Paton, 1956; Tolmie, Joyce and Mitchell, 1967; Weintraub, Heisterkamp and Cooperman, 1969; Powell, 1970; Miller et al., 1972) . However, it is not known if the suxamethonium-induced hyperkalaemia varies with the anaesthetic agent that has been used for the induction of anaesthesia.
PATIENTS AND METHODS
Studies were performed on 101 patients of average age 28 years (range 4-65 years). There were 75 male and 26 female patients, all of whom were selected as uncomplicated cases expected to have a normal serum potassium concentration. The patients were divided into three groups according to the technique used for induction of anaesthesia (table I) .
All the patients were premedicated with atropine and pethidine. In Group I (except Group I (f)) anaesthesia was induced with an inhalation technique comprising preoxygenation for 3 min followed by 100% nitrous oxide for five to six breaths, and maintenance with nitrous oxide and oxygen (70:30%) with slow introduction of the volatile anaesthetic into the mixture until the eyelash reflex was abolished. Suxamethonium was then administered intravenously in a dose of 1 mg/kg body wt. Following endotracheal intubation, the patients were ventilated manually using a Magill circuit until spontaneous ventilation was reestablished. Patients in Group I (f) and Group II were treated in a similar manner apart from the fact that the latter were given tubocurarine 3 mg intravenously 2-3 min before induction of anaesthesia. Induction of anaesthesia was with thiopentone (5 mg/kg body wt.) followed by suxamethonium (1 mg/kg body wt) and, following endotracheal intubation, anaesthesia was maintained with nitrous oxide and oxygen via a Magill circuit.
With the patients in Group HI, anaesthesia was induced with thiopentone (5 mg/kg body wt.) followed by suxamethonium (1 mg/kg body wt.); the trachea was intubated, and ventilation was controlled manually using a closed circuit with carbon dioxide absorption and intermittent suxamethonium given intravenously.
In the patients in Group I and II, 4-ml blood samples were withdrawn from the antecubital vein into a dry sterile syringe at 1, 3, 5, 7.5 and 15 min following the injection of suxamethonium. In the patients in Group HI, samples were taken at 5, 10, 15, and 20 min following the first injection of suxamethonium and a final sample was taken at the end of the operation.
Blood samples were centrifuged at 3000 r.p.m., and care was taken to see that no haemolysis of samples occurred. The potassium concentration in the supernatant serum was estimated using a standard flame photometric method (EEL).
RESULTS
In the control group of patients who were not given suxamethonium, there was no statistically significant change in serum potassium concentration during maintenance of anaesthesia with nitrous oxide (Group I (a)).
There were no significant differences in the serum potassium concentrations between the groups of patients before induction of anaesthesia (tables II, HI, IV), and in the control group of patients there were no significant changes in serum potassium concentration during induction and maintenance of anaesthesia (Group I (a), table II). However, in all the other groups of patients there were statistically significant increases in serum potassium. The maximum increase in serum potassium concentration occurred in the patients anaesthetized with trichloroethylene while the changes in the groups anaesthetized with ether, chloroform and halothane were of approximately the same order. Pretreatment with tubocurarine 3 mg produced a reduction in the response, but the increase in serum potassium at 3 min was significantly greater than the concentration before induction (table HI) . DISCUSSION It is interesting that there was such a wide variation of change in serum potassium concentrations following different anaesthetic induction agents. In the first group, the patients anaesthetized with trichloroethylene exhibited the largest percentage increase in serum potassium (21.4% with a change of 0.8 m-equiv/litre) whereas the patients anaesthetized with halo thane exhibited a 15.1% increase in serum potassium concentration. From this we infer that both the depolarizing muscle relaxants and the induction agent play a role in the increased serum potassium. Although the role of the latter appears to be obscure, Powell and Golby (1971) postulated that both depolarizing muscle relaxants and acute increases in carbon dioxide tension may provoke hyperkalaemia, and that these effects may be additive. All our patients were premedicated with pethidine, which is known to produce respiratory depression, but we do not know to what extent the arterial PcOj changed during induction of anaesthesia. Stevenson (1960) , List (1967) and Weintraub, Heisterkamp and Cooperman (1969) have reported increases in serum potassium following the administration of suxamethonium. Studying only two induction agents (halothane and thiopentone) and using 100 mg of suxamethonium, the maTi'mnm increase in serum potassium concentration was found to be 0.55 m-equiv/litre. In our study the mean maximum increase with the same induction techniques was 0.76 m-equiv/litre using thiopentone and 0.61 m-equiv/litre using halothane.
In the second group of patients who received tubocurarine before induction of anaesthesia with thiopentone there were no fasdculations following the administration of suxamethonium. The increase in the serum potassium concentration was only 10.6% with an absolute value of 0.3 m-equiv/litre. Where fasdculations were present (Group I (f)) the increase in serum potassium was between 15.1-21.4%. However, it should be noted that even after pretreatment with tubocurarine there was a statistically significant increase in serum potassium following suxamethonium.
Using intermittent administration of suxamethonium (Group HI) the maximum increase in serum potassium was 18.8% compared with the maximum increase of 19.7% following a single suxamethonium injection after the same induction technique. This is not in accord with the observations of Tolmie, Joyce and Mitchell (1967) who reported a dose response relationship.
From this study we condude that the increase in serum potassium is a result of a combination of induction agent and suxamethonium rather than the effect of suxamethonium alone, and we make the following suggestions:
(1) It is established that in cases of burns, uraemia, massive musde trauma and similar conditions, there is a considerable hyperkalaemia following suxamethonium. If the induction agent is trichloroethylene or thiopentone, the resulting hyperkalaemia may be of a greater magnitude. We would suggest that where it is not possible to avoid the use of suxamethonium it is preferable to use halothane as an induction agent.
(2) As an alternative technique we suggest that 3 mg of tubocurarine given before induction of anaesthesia will approximately halve the resulting hyperkalaemia following injection of suxamethonium. 
